Is Troglitazone a Real Indication for Obese Subjects With Impaired Glucose Tolerance?

Yoshioka, Keiji; Yokoo, Sadayoshi; Yoshida, Toshihide; Kondo, Motoharu

doi:10.2337/diacare.20.8.1340b

Article navigation

Letters| August 01 1997

Is Troglitazone a Real Indication for Obese Subjects With Impaired Glucose Tolerance?

Keiji Yoshioka, MD;

Keiji Yoshioka, MD

Department of Internal Medicine, Matsushita Memorial Hospital

Moriguchi, Osaka

Department of Internal Medicine, Kyoto Prefectural University of Medicine

Kyoto, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Sadayoshi Yokoo, MD;

Sadayoshi Yokoo, MD

Department of Internal Medicine, Matsushita Memorial Hospital

Moriguchi, Osaka

Search for other works by this author on:

This Site

PubMed

Google Scholar

Toshihide Yoshida, MD;

Toshihide Yoshida, MD

Department of Internal Medicine, Kyoto Prefectural University of Medicine

Kyoto, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Motoharu Kondo, MD

Department of Internal Medicine, Kyoto Prefectural University of Medicine

Kyoto, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to K. Yoshioka, MD, First Department of Internal Medicine, Matsushita Memorial Hospital, Moriguchi, Osaka 570, Japan.

Diabetes Care 1997;20(8):1340–1341

https://doi.org/10.2337/diacare.20.8.1340b

PubMed:

9250469

Is Troglitazone a Real Indication for Obese Subjects With Impaired Glucose Tolerance?

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Is Troglitazone a Real Indication for Obese Subjects With Impaired Glucose Tolerance?

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only